Kuoppamäki M - Search Results

1

Unilateral pallidotomy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets exhibiting levodopa-induced dyskinesia.

Iravani MM, Costa S, Al-Bargouthy G, Jackson MJ, Zeng BY, Kuoppamäki M, Obeso JA, Jenner P. Iravani MM, et al. Among authors: kuoppamaki m. Eur J Neurosci. 2005 Sep;22(6):1305-18. doi: 10.1111/j.1460-9568.2005.04308.x. Eur J Neurosci. 2005. PMID: 16190886

2

MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome.

Zeng BY, Iravani MM, Lin ST, Irifune M, Kuoppamäki M, Al-Barghouthy G, Smith L, Jackson MJ, Rose S, Medhurst AD, Jenner P. Zeng BY, et al. Among authors: kuoppamaki m. Eur J Neurosci. 2006 Apr;23(7):1766-74. doi: 10.1111/j.1460-9568.2006.04718.x. Eur J Neurosci. 2006. PMID: 16623833

3

L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates.

Kuoppamäki M, Al-Barghouthy G, Jackson MJ, Smith LA, Quinn N, Jenner P. Kuoppamäki M, et al. J Neural Transm (Vienna). 2007 Sep;114(9):1147-53. doi: 10.1007/s00702-007-0727-3. Epub 2007 Apr 20. J Neural Transm (Vienna). 2007. PMID: 17446998

4

Beginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with levodopa.

Kuoppamäki M, Al-Barghouthy G, Jackson M, Smith L, Zeng BY, Quinn N, Jenner P. Kuoppamäki M, et al. Mov Disord. 2002 Nov;17(6):1312-7. doi: 10.1002/mds.10263. Mov Disord. 2002. PMID: 12465074

5

3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates.

Iravani MM, Jackson MJ, Kuoppamäki M, Smith LA, Jenner P. Iravani MM, et al. Among authors: kuoppamaki m. J Neurosci. 2003 Oct 8;23(27):9107-15. doi: 10.1523/JNEUROSCI.23-27-09107.2003. J Neurosci. 2003. PMID: 14534244 Free PMC article.

6

Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates.

Smith LA, Jackson MJ, Al-Barghouthy G, Rose S, Kuoppamaki M, Olanow W, Jenner P. Smith LA, et al. Among authors: kuoppamaki m. Mov Disord. 2005 Mar;20(3):306-14. doi: 10.1002/mds.20317. Mov Disord. 2005. PMID: 15490461

7

Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates.

Smith LA, Jackson MJ, Johnston L, Kuoppamaki M, Rose S, Al-Barghouthy G, Del Signore S, Jenner P. Smith LA, et al. Among authors: kuoppamaki m. Clin Neuropharmacol. 2006 May-Jun;29(3):112-25. doi: 10.1097/01.WNF.0000220818.71231.DF. Clin Neuropharmacol. 2006. PMID: 16772809

8

Progressive delayed-onset dystonia after cerebral anoxic insult in adults.

Kuoppamäki M, Bhatia KP, Quinn N. Kuoppamäki M, et al. Mov Disord. 2002 Nov;17(6):1345-9. doi: 10.1002/mds.10260. Mov Disord. 2002. PMID: 12465080

9

Slowly progressive cerebellar ataxia and cervical dystonia: clinical presentation of a new form of spinocerebellar ataxia?

Kuoppamäki M, Giunti P, Quinn N, Wood NW, Bhatia KP. Kuoppamäki M, et al. Mov Disord. 2003 Feb;18(2):200-6. doi: 10.1002/mds.10308. Mov Disord. 2003. PMID: 12539216 Review.

10

Parkinsonism following bilateral lesions of the globus pallidus: performance on a variety of motor tasks shows similarities with Parkinson's disease.

Kuoppamäki M, Rothwell JC, Brown RG, Quinn N, Bhatia KP, Jahanshahi M. Kuoppamäki M, et al. J Neurol Neurosurg Psychiatry. 2005 Apr;76(4):482-90. doi: 10.1136/jnnp.2003.020800. J Neurol Neurosurg Psychiatry. 2005. PMID: 15774432 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters